N-terminal telopeptide (NTX) as a prognostic and predictive Marker of Bone Metastases in Breast Cancer patients after receiving bone supporting agents - Egyptian Knowledge Bank - troweb

297301

N-terminal telopeptide (NTX) as a prognostic and predictive Marker of Bone Metastases in Breast Cancer patients after receiving bone supporting agents

Article

Last updated: 03 Jan 2025

Overview Similar Items

Article

THE PROGNOSTIC AND PREDICTIVE VALUE OF SERUM BONE BIOMARKER (CTX) IN PATIENTS WITH BREAST CANCER METASTATIC TO BONE RECEIVING ZOLEDRONIC ACID

Thesis

Value of bone resorption markers to predict skeletal related events and response to bisphosphonate therapy in patients with bone metastases

Article

Predictive value of biological markers in loco-regional recurrence of breast cancer after mastectomy and radiotherapy

Thesis

Biochemical markers of bone metabolism in breast cancer patients with bone metastases

Article

Relationship between Hyperprolactinemia and Bone Metabolic Markers in Breast Cancer Patients

Article

Bone Densitometry Measurement for Early Breast Cancer Patients

Article

Study of Distribution of Bone Metastases in Metastatic Breast Cancer Patients Compared to Other Major Cancers

Article

ASSESMENT OF PROGNOSTIC VALUE OF METASTATIC FREE INTERVAL AS OVERALL SURVIVAL SURROGATE IN METASTATIC BREAST CANCER FEMALE PATIENTS

Thesis

Biochemical markers of bone metabolism in breast cancer patients with bone metastases

Article

COX-2 “Cyclooxygenase 2“as a Prognostic marker in Breast Cancer